Clinical Trials · NCT02160353

Neo-adjuvant Abiraterone Prostate Study

Name: Neo-adjuvant Abiraterone Prostate Study
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 2Gonadorelin

Phase: Phase 2
Recruitment status: Completed
Sponsor: Cancer Trials Ireland
Enrollment: 45
Start date: Jul 2015
Locations: 3 sites, Ireland
Primary endpoint: Clinical tumour response

View Gonadorelin compound reference